Pacific Biosciences of California Cash Flow Reinvestment Rate
Pacific Biosciences of California cash flow reinvestment rate. Pacific Biosciences of California (PACB) has a Cash Flow Reinvestment Rate of 0.72x as of March 2020, reinvesting $54.33 Million (capex $117.00K plus investments $-54.21 Million) from operating cash flow of $75.36 Million. Explore Pacific Biosciences of California (PACB) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Pacific Biosciences of California (2020–2020)
Cash flow reinvestment rate of Pacific Biosciences of California from 2020 to 2020. Historical reinvestment intensity for Pacific Biosciences of California across 1 annual periods. Explore how much does Pacific Biosciences of California reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Pacific Biosciences of California Cash Flow Reinvestment Rate by Year (2020–2020)
Pacific Biosciences of California cash flow reinvestment rate by year from 2020 to 2020. Year-by-year capital reinvestment analysis for Pacific Biosciences of California. For the full cash flow conversion analysis, see cash flow conversion of Pacific Biosciences of California.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 11.25x | $219.32 Million | $19.50 Million | $1.04 Million | — |